Reverse Thiazine Kinase Inhibitors
US Application 63/672,577
Filed on 2024-07-17
Filed on 2024-07-17
TEM8 MONOCLONAL ANTIBODIES AND THEIR USE
US Application 63/750,425
Filed on 2025-01-28
Filed on 2025-01-28
PHOTOACTIVATABLE DYE COMPOUNDS FOR CONJUGATE FORMATION AND METHODS OF MAKING AND USING THE SAME
US Application 63/690,585
Filed on 2024-09-04
Filed on 2024-09-04
INTEGRASE STRAND TRANSFER INHIBITORS
US Application 63/707,882
Filed on 2024-10-16
Filed on 2024-10-16
INDUCED NATURAL KILLER CELLS EXPRESSING A MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTOR AND INTERLEUKIN-15 FOR THE TREATMENT OF SOLID TUMORS
US Application 63/647,371
Filed on 2024-05-14
Filed on 2024-05-14
T CELL RECEPTORS AGAINST RAS WITH G12D, G12V, G13D OR Q61R MUTATION
US Application 63/673,840
Filed on 2024-07-22
Filed on 2024-07-22
DRUG-REGULATABLE, INDUCIBLE CYTOKINE EXPRESSION
US Application 63/652,871
Filed on 2024-05-29
Filed on 2024-05-29
MULTIFUNCTIONAL MOLECULES BINDING TO TCR AND USES THEREOF
US Application 63/633,193
Filed on 2024-04-12
Filed on 2024-04-12
COMPOSITIONS AND METHODS FOR THE MANIPULATION OF FUNCTIONAL LONG LIVED PLASMA CELL (LLPC) POPULATIONS AND USE THEREOF FOR TREATMENT AND MODULATION OF DISEASE
US Application 63/552,069
Filed on 2024-02-09
Filed on 2024-02-09